Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Vandewalle
Php243 - Do Disease Severity and/or Quality of Clinical Data Influence Pricing Policy in France? An Analysis on Orphan Drugs and Blood Cancers Treatments
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Orphan Drug Pricing in France: Influence of Main Factors
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Determinants of Orphan Drugs Prices in France: A Regression Analysis
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
Pricing and Reimbursement of Orphan Drugs: The Need for More Transparency
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
Potential Impact of the Cancer Drugs Fund Reform on Orphan Cancers
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Pricing of Breakthrough Drugs: Theory and Policy Implications
PLoS ONE
Multidisciplinary
Substantiation of the National Policy of Pricing and Availability of Drugs
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Novel Treatments for Rare Cancers: The U.S. Orphan Drug Act Is Delivering—A Cross-Sectional Analysis
Oncologist
Cancer Research
Medicine
Oncology
An Analysis of Reconstituted Fluid Milk Pricing Policy
American Journal of Agricultural Economics
Agricultural
Economics
Econometrics
Biological Sciences
An Indecent Proposal or Improved Quality of Bioanalytical Data in Clinical Studies
Bioanalysis
Pharmacology
Analytical Chemistry
Medical Laboratory Technology
Clinical Biochemistry
Medicine
Toxicology
Pharmaceutics
